{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:28:41Z","timestamp":1792801721192,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,12,27]],"date-time":"2011-12-27T00:00:00Z","timestamp":1324944000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s11064-011-0682-0","type":"journal-article","created":{"date-parts":[[2011,12,26]],"date-time":"2011-12-26T11:41:57Z","timestamp":1324899717000},"page":"875-884","source":"Crossref","is-referenced-by-count":55,"title":["Role of Secondary Mediators in Caffeine-Mediated Neuroprotection in Maneb- and Paraquat-Induced Parkinson\u2019s Disease Phenotype in the Mouse"],"prefix":"10.1007","volume":"37","author":[{"given":"Sharawan","family":"Yadav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satya Prakash","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garima","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramod Kumar","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahendra Pratap","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,27]]},"reference":[{"key":"682_CR1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00441-004-0975-6","volume":"318","author":"T Klockgether","year":"2004","unstructured":"Klockgether T (2004) Parkinson\u2019s disease: clinical aspects. Cell Tissue Res 318:115\u2013120","journal-title":"Cell Tissue Res"},{"key":"682_CR2","first-page":"69","volume":"43","author":"MP Singh","year":"2006","unstructured":"Singh MP, Patel S, Dikshit M, Gupta YK (2006) Contribution of genomics and proteomics in understanding the role of modifying factors in Parkinson\u2019s disease. Indian J Biochem Biophys 43:69\u201381","journal-title":"Indian J Biochem Biophys"},{"key":"682_CR3","first-page":"373","volume":"6","author":"S Patt","year":"1991","unstructured":"Patt S, Gertz HJ, Gerhard L, Cervos-Navarro J (1991) Pathological changes in dendrites of substantia nigra neurons in Parkinson\u2019s disease: a Golgi study. Histol Histopathol 6:373\u2013380","journal-title":"Histol Histopathol"},{"key":"682_CR4","first-page":"17","volume":"40","author":"CM Tanner","year":"1990","unstructured":"Tanner CM, Langston JW (1990) Do environmental toxins cause Parkinson\u2019s disease? A critical review. Neurology 40:17\u201330","journal-title":"Neurology"},{"key":"682_CR5","doi-asserted-by":"crossref","first-page":"9207","DOI":"10.1523\/JNEUROSCI.20-24-09207.2000","volume":"20","author":"M Thiruchelvam","year":"2000","unstructured":"Thiruchelvam M, Richfield EK, Baggs RB et al (2000) The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson\u2019s disease. J Neurosci 20:9207\u20139214","journal-title":"J Neurosci"},{"key":"682_CR6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.brainres.2006.01.060","volume":"1081","author":"S Patel","year":"2006","unstructured":"Patel S, Singh V, Kumar A et al (2006) Status of antioxidant defense system and expression of toxicant responsive genes in striatum of maneb and paraquat-induced Parkinson\u2019s disease phenotype in mouse: mechanism of neurodegeneration. Brain Res 1081:9\u201318","journal-title":"Brain Res"},{"key":"682_CR7","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.neurobiolaging.2010.02.018","volume":"33","author":"AK Singh","year":"2012","unstructured":"Singh AK, Tiwari MN, Upadhyay G et al (2012) Long-term exposure to cypermethrin induces the nigrostriatal dopaminergic neurodegeneration in adult rats: postnatal exposure enhances the susceptibility during adulthood. Neurobiol Aging 33:404\u2013415","journal-title":"Neurobiol Aging"},{"key":"682_CR8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cbi.2010.03.015","volume":"185","author":"K Singh","year":"2010","unstructured":"Singh K, Singh S, Singhal NK et al (2010) Nicotine- and caffeine-mediated changes in gene expression patterns of MPTP-lesioned mouse striatum: implications in neuroprotection mechanism. Chem Biol Interact 185:81\u201393","journal-title":"Chem Biol Interact"},{"key":"682_CR9","first-page":"31","volume":"50","author":"B Thrash","year":"2007","unstructured":"Thrash B, Uthayathas S, Karuppagounder SS et al (2007) Paraquat and maneb induced neurotoxicity. Proc West Pharmacol Soc 50:31\u201342","journal-title":"Proc West Pharmacol Soc"},{"key":"682_CR10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1586\/epr.09.91","volume":"7","author":"G Srivastava","year":"2010","unstructured":"Srivastava G, Singh K, Tiwari MN, Singh MP (2010) Proteomics in Parkinson\u2019s disease: current trends, translational snags and future possibilities. Expert Rev Proteomics 7:127\u2013139","journal-title":"Expert Rev Proteomics"},{"key":"682_CR11","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0161-813X(02)00092-X","volume":"23","author":"M Thiruchelvam","year":"2002","unstructured":"Thiruchelvam M, Richfield EK, Goodman BM et al (2002) Developmental exposure to the pesticides paraquat and maneb and the Parkinson\u2019s disease phenotype. Neurotoxicology 23:621\u2013633","journal-title":"Neurotoxicology"},{"key":"682_CR12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s12033-008-9060-9","volume":"40","author":"S Patel","year":"2008","unstructured":"Patel S, Singh K, Singh S, Singh MP (2008) Gene expression profiles of mouse striatum in control and maneb + paraquat-induced Parkinson\u2019s disease phenotype: validation of differentially expressed energy metabolizing transcripts. Mol Biotechnol 40:59\u201368","journal-title":"Mol Biotechnol"},{"key":"682_CR13","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.expneurol.2010.02.007","volume":"223","author":"A Kachroo","year":"2010","unstructured":"Kachroo A, Irizarry MC, Schwarzschild MA (2010) Caffeine protects against combined paraquat and maneb-induced dopaminergic neuron degeneration. Exp Neurol 223:657\u2013661","journal-title":"Exp Neurol"},{"key":"682_CR14","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1007\/s11064-010-0176-5","volume":"35","author":"SP Gupta","year":"2010","unstructured":"Gupta SP, Patel S, Yadav S et al (2010) Involvement of nitric oxide in maneb- and paraquat-induced Parkinson\u2019s disease phenotype in mouse: is there any link with lipid peroxidation? Neurochem Res 35:1206\u20131213","journal-title":"Neurochem Res"},{"key":"682_CR15","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.nbd.2005.03.018","volume":"20","author":"F Cicchetti","year":"2005","unstructured":"Cicchetti F, Lapointe N, Roberge-Tremblay A et al (2005) Systemic exposure to paraquat and maneb models early Parkinson\u2019s disease in young adult rats. Neurobiol Dis 20:360\u2013371","journal-title":"Neurobiol Dis"},{"key":"682_CR16","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0031-6997(24)01511-4","volume":"53","author":"BB Fredholm","year":"2001","unstructured":"Fredholm BB, Ijzerman AP, Jacobson KA et al (2001) International union of pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53:527\u2013552","journal-title":"Pharmacol Rev"},{"key":"682_CR17","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1001\/jama.283.20.2674","volume":"283","author":"GW Ross","year":"2000","unstructured":"Ross GW, Abbott RD, Petrovitch H et al (2000) Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA 283:2674\u20132679","journal-title":"JAMA"},{"key":"682_CR18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/ana.1052","volume":"50","author":"A Ascherio","year":"2001","unstructured":"Ascherio A, Zhang SM, Hern\u00e1n MA et al (2001) Prospective study of caffeine consumption and risk of Parkinson\u2019s disease in men and women. Ann Neurol 50:56\u201363","journal-title":"Ann Neurol"},{"key":"682_CR19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.brainres.2009.06.002","volume":"1283","author":"S Singh","year":"2009","unstructured":"Singh S, Singh K, Gupta SP et al (2009) Effect of caffeine on the expression of cytochrome P450 1A2, adenosine A2A receptor and dopamine transporter in control and 1-methyl 4-phenyl 1, 2, 3, 6-tetrahydropyridine treated mouse striatum. Brain Res 1283:115\u2013126","journal-title":"Brain Res"},{"key":"682_CR20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.brainres.2008.02.023","volume":"1207","author":"S Singh","year":"2008","unstructured":"Singh S, Singh K, Patel S et al (2008) Nicotine and caffeine-mediated modulation in the expression of toxicant responsive genes and vesicular monoamine transporter-2 in 1-methyl 4-phenyl-1, 2, 3, 6-tetrahydropyridine\u2019induced Parkinson\u2019s disease phenotype in mouse. Brain Res 1207:193\u2013206","journal-title":"Brain Res"},{"key":"682_CR21","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0165-6147(97)90660-X","volume":"18","author":"PJ Richardson","year":"1997","unstructured":"Richardson PJ, Kase H, Jenner PG (1997) Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson-s disease. Trends Pharmacol Sci 18:338\u2013344","journal-title":"Trends Pharmacol Sci"},{"key":"682_CR22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0306-4522(00)00250-5","volume":"100","author":"M Ochi","year":"2000","unstructured":"Ochi M, Koga K, Kurokawa M et al (2000) Systemic administration of adenosine A2A receptor antagonist reverses increased GABA release in the globus pallidus of unilateral 6-hydroxydopamine-lesioned rats: a microdialysis study. Neuroscience 100:53\u201362","journal-title":"Neuroscience"},{"key":"682_CR23","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nature00817","volume":"418","author":"M Lindskog","year":"2002","unstructured":"Lindskog M, Svenningsson P, Pozzi L (2002) Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine. Nature 418:774\u2013778","journal-title":"Nature"},{"key":"682_CR24","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1471-4159.2008.05697.x","volume":"107","author":"X Chen","year":"2008","unstructured":"Chen X, Lan X, Roche I et al (2008) Caffeine protects against MPTP-induced blood\u2013brain barrier dysfunction in mouse striatum. J Neurochem 107:1147\u20131157","journal-title":"J Neurochem"},{"key":"682_CR25","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.neulet.2007.12.034","volume":"432","author":"K Nakaso","year":"2008","unstructured":"Nakaso K, Ito S, Nakashima K (2008) Caffeine activates the PI3\u00a0K\/Akt pathway and prevents apoptotic cell death in a Parkinson\u2019s disease model of SH-SY5Y cells. Neurosci Lett 432:146\u2013150","journal-title":"Neurosci Lett"},{"key":"682_CR26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1600-079X.2010.00819.x","volume":"50","author":"NK Singhal","year":"2011","unstructured":"Singhal NK, Srivastava G, Patel DK et al (2011) Melatonin or silymarin reduces maneb- and paraquat-induced Parkinson\u2019s disease phenotype in the mouse. J Pineal Res 50:97\u2013109","journal-title":"J Pineal Res"},{"key":"682_CR27","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/toxsci\/kfr115","volume":"122","author":"AK Singh","year":"2011","unstructured":"Singh AK, Tiwari MN, Dixit A et al (2011) Nigrostriatal proteomics of cypermethrin-induced dopaminergic neurodegeneration: microglial activation dependent and independent regulations. Toxicol Sci 122:526\u2013538","journal-title":"Toxicol Sci"},{"key":"682_CR28","doi-asserted-by":"crossref","first-page":"F559","DOI":"10.1152\/ajprenal.00309.2001","volume":"283","author":"PY Martin","year":"2002","unstructured":"Martin PY, Bianchi M, Roger F et al (2002) Arginine vasopressin modulates expression of neuronal NOS in rat renal medulla. Am J Physiol Renal Physiol 283:F559\u2013F568","journal-title":"Am J Physiol Renal Physiol"},{"key":"682_CR29","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248\u2013254","journal-title":"Anal Biochem"},{"key":"682_CR30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1006\/nbdi.2002.0507","volume":"10","author":"AL McCormack","year":"2002","unstructured":"McCormack AL, Thiruchelvam M, Manning-Bog AB et al (2002) Environmental risk factors and Parkinson\u2019s disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat. Neurobiol Dis 10:119\u2013127","journal-title":"Neurobiol Dis"},{"key":"682_CR31","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.ntt.2007.04.002","volume":"29","author":"S Patel","year":"2007","unstructured":"Patel S, Sinha A, Singh MP (2007) Identification of differentially expressed proteins in striatum of maneb- and paraquat-induced Parkinson\u2019s disease phenotype in mouse. Neurotoxicol Teratol 29:578\u2013585","journal-title":"Neurotoxicol Teratol"},{"key":"682_CR32","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0306-4522(90)90229-W","volume":"39","author":"LJ Lawson","year":"1990","unstructured":"Lawson LJ, Perry VH, Dri P, Gordon S (1990) Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39:151\u2013170","journal-title":"Neuroscience"},{"key":"682_CR33","doi-asserted-by":"crossref","first-page":"6309","DOI":"10.1523\/JNEUROSCI.20-16-06309.2000","volume":"20","author":"WG Kim","year":"2000","unstructured":"Kim WG, Mohney RP, Wilson B et al (2000) Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J Neurosci 20:6309\u20136316","journal-title":"J Neurosci"},{"key":"682_CR34","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1089\/ars.2005.7.654","volume":"7","author":"XF Wu","year":"2005","unstructured":"Wu XF, Block ML, Zhen W et al (2005) The role of microglia in paraquat-induced dopaminergic neurotoxicity. Antioxid Redox Signal 7:654\u2013661","journal-title":"Antioxid Redox Signal"},{"key":"682_CR35","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1074\/mcp.M500114-MCP200","volume":"4","author":"Y Zhou","year":"2005","unstructured":"Zhou Y, Wang Y, Kovacs M et al (2005) Microglial activation induced by neurodegeneration: a proteomic analysis. Mol Cell Proteomics 4:1471\u20131479","journal-title":"Mol Cell Proteomics"},{"key":"682_CR36","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1523\/JNEUROSCI.22-03-00782.2002","volume":"22","author":"HM Gao","year":"2002","unstructured":"Gao HM, Hong JS, Zhang W, Liu B (2002) Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons. J Neurosci 22:782\u2013790","journal-title":"J Neurosci"},{"key":"682_CR37","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","volume":"38","author":"PL McGeer","year":"1988","unstructured":"McGeer PL, Itagaki S, Boyes BE, McGeer EG (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains. Neurology 38:1285\u20131291","journal-title":"Neurology"},{"key":"682_CR38","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1093\/brain\/awn101","volume":"131","author":"MC Pott Godoy","year":"2008","unstructured":"Pott Godoy MC, Tarelli R, Ferrar CC et al (2008) Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson\u2019s disease. Brain 131:1880\u20131894","journal-title":"Brain"},{"key":"682_CR39","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12026-008-8018-0","volume":"41","author":"L Qian","year":"2008","unstructured":"Qian L, Flood PM (2008) Microglial cells and Parkinson\u2019s disease. Immunol Res 41:155\u2013164","journal-title":"Immunol Res"},{"key":"682_CR40","doi-asserted-by":"crossref","first-page":"7531","DOI":"10.1073\/pnas.94.14.7531","volume":"94","author":"S Hunot","year":"1997","unstructured":"Hunot S, Brugg B, Ricard D et al (1997) Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with Parkinson disease. Proc Natl Acad Sci USA 94:7531\u20137536","journal-title":"Proc Natl Acad Sci USA"},{"key":"682_CR41","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1172\/JCI11830","volume":"107","author":"PP Tak","year":"2001","unstructured":"Tak PP, Firestein GS (2001) NF-kappaB: a key role in inflammatory diseases. J Clin Invest 107:7\u201311","journal-title":"J Clin Invest"},{"key":"682_CR42","doi-asserted-by":"crossref","first-page":"712","DOI":"10.4049\/jimmunol.153.2.712","volume":"153","author":"JP Cogswell","year":"1994","unstructured":"Cogswell JP, Godlevski MM, Wisely GB et al (1994) NF-kappa B regulates IL-1 beta transcription through a consensus NF-kappa B binding site and a nonconsensus CRE-like site. J Immunol 153:712\u2013723","journal-title":"J Immunol"},{"key":"682_CR43","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1096\/fj.02-0314fje","volume":"17","author":"H Wilms","year":"2003","unstructured":"Wilms H, Rosenstiel P, Sievers J et al (2003) Activation of microglia by human neuromelanin is NF-kappaB dependent and involves p38 mitogen-activated protein kinase: implications for Parkinson\u2019s disease. FASEB J 17:500\u2013502","journal-title":"FASEB J"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-011-0682-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-011-0682-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-011-0682-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,16]],"date-time":"2025-03-16T16:53:51Z","timestamp":1742144031000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-011-0682-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,27]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["682"],"URL":"https:\/\/doi.org\/10.1007\/s11064-011-0682-0","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,27]]}}}